| Dr Patricia Banke, DNP-PMHNP | |
|
430 Cox Rd, Greer, SC 29651-7260 | |
| (864) 872-5720 | |
| Not Available |
| Full Name | Dr Patricia Banke |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 430 Cox Rd, Greer, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144851742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 23901 (South Carolina) | Primary |
| Entity Name | Itrust Wellness Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629517222 PECOS PAC ID: 0648532028 Enrollment ID: O20180322002663 |
News Archive
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
More than 60 percent of women who undergo a mastectomy to treat breast cancer choose breast reconstruction, and the demand for that surgery is rising. However, due to the previous lack of evidence-based, patient-centered data available about post-breast reconstruction, most patients aren't properly informed about satisfaction and quality-of-life measures over time.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced a strategic alliance agreement with the University of Pretoria as part of its industry unique Prime Site program, an initiative to accelerate the development of new and more effective medicines.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses. These and accompanying findings are likely to lead to less-toxic, better-targeted treatment approaches over the next two years, the researchers said.
› Verified 3 days ago
| Entity Name | Pathway |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306517628 PECOS PAC ID: 6002206075 Enrollment ID: O20211206001966 |
News Archive
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
More than 60 percent of women who undergo a mastectomy to treat breast cancer choose breast reconstruction, and the demand for that surgery is rising. However, due to the previous lack of evidence-based, patient-centered data available about post-breast reconstruction, most patients aren't properly informed about satisfaction and quality-of-life measures over time.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced a strategic alliance agreement with the University of Pretoria as part of its industry unique Prime Site program, an initiative to accelerate the development of new and more effective medicines.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses. These and accompanying findings are likely to lead to less-toxic, better-targeted treatment approaches over the next two years, the researchers said.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia Banke, DNP-PMHNP 2607 Woodruff Rd # 1215, Simpsonville, SC 29681-4803 Ph: (864) 743-0060 | Dr Patricia Banke, DNP-PMHNP 430 Cox Rd, Greer, SC 29651-7260 Ph: (864) 872-5720 |
News Archive
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
More than 60 percent of women who undergo a mastectomy to treat breast cancer choose breast reconstruction, and the demand for that surgery is rising. However, due to the previous lack of evidence-based, patient-centered data available about post-breast reconstruction, most patients aren't properly informed about satisfaction and quality-of-life measures over time.
Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced a strategic alliance agreement with the University of Pretoria as part of its industry unique Prime Site program, an initiative to accelerate the development of new and more effective medicines.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses. These and accompanying findings are likely to lead to less-toxic, better-targeted treatment approaches over the next two years, the researchers said.
› Verified 3 days ago
Mrs. Kristin Nicole Tolley, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3308 Brushy Creek Rd, Greer, SC 29650 Phone: 864-752-2000 | |
Dr. Wanda Sexton Samake, DNP, PMHNP, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 John St Unit 5b, Greer, SC 29651 Phone: 864-990-5664 Fax: 864-990-5674 | |
Robyn White, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 119 Chandler Crest Ct, Greer, SC 29651 Phone: 917-561-8382 | |
Heather Ann Traynham, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2755 S Highway 14 Ste 2200, Greer, SC 29650 Phone: 864-849-9555 Fax: 864-849-9556 | |
Melissa Hope Suttell, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 206a S Main St, Greer, SC 29650 Phone: 864-989-0230 Fax: 864-334-1880 | |
Elizabeth Ireland, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 230 W Wade Hampton Blvd, Greer, SC 29650 Phone: 864-968-9144 |